Did you know?
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.
Did you know?
Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.
Did you know?
As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.
Did you know?
Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.
Did you know?
Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.
Like most world-changing inventions, the printing press of fifteenth-century Europe took advantage o
Bone Resorption Inhibitors and Selected Drugs
Isozymes of Cytochrome P450: Selected Substrates, Inducers, and Inhibitors
A diploma or certificate is proof of education completed.
Researchers and Research Spending, 2009
RESEARCH TECHNIQUE